All In MedTech

Device Trial Radar · NCT03034213

Gentrix™ Versus Biological or Prosthetic Mesh

Randomized, Controlled Trial Comparing Separation of Components Repair With Retrorectus Gentrix™ Surgical Matrix Versus Biological or Prosthetic Mesh for Open Ventral Hernia Repair

Last checked: Nov 19, 2026Latest source record: Sep 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

17

Actual

Start

Oct 6, 2017

Primary completion

Jun 16, 2021

Study completion Jun 16, 2021

Sponsor

Lead sponsor
University of South FloridaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Integra LifeSciences Corporation
First posted
Jan 27, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The hypothesis for this study is complex incisional hernia repair using the separation of components technique reinforced with retrorectus placement of Gentrix™ Surgical Matrix will lead to fewer incisional hernia recurrences and fewer wound complications compared to the same incisional hernia repair techniques reinforced with other prosthetic or biologically-derived mesh.

Conditions

  • Ventral Incisional Hernia

Interventions

  • Gentrix™ Surgical Matrix (Treatment)Device

    Gentrix™ Surgical Matrix will be placed in the retrorectus space. The anterior midline fascia will be closed with long-acting absorbable suture either with a running or interrupted manner as per the surgeon's discretion.

  • Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend (Control)Device

    A biological or prosthetic mesh (Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend) will be placed in the retrorectus space. The anterior midline fascia will be closed with long-acting absorbable suture either with a running or interrupted manner as per the surgeon's discretion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of incisional hernia recurrenceTime frame: 2 years from study incisional hernia repair

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Tampa General Hospital

    Tampa, Florida

  • University of South Florida - South Tampa Campus

    Tampa, Florida

  • University of South Florida Morsani Center for Advanced Health Care

    Tampa, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.